Howard Hochster assumed the role of associate director for clinical research and chief of gastrointestinal medical oncology at Rutgers Cancer Institute, as well as director of cancer clinical research for oncology services at RWJBarnabas Health.
Timothy Whitten was named president of Taiho Oncology Inc., a subsidiary of Taiho Pharmaceutical Co. Ltd.
Purdue University's Center for Cancer Research received a $10 million matching-funds gift from the Indianapolis-based Walther Cancer Foundation to advance its research in drug discovery, treatments and potential cures.
METAvivor Research and Support Inc., a non-profit organization dedicated to funding research for stage IV metastatic breast cancer, announced twelve grant awards totaling $1,650,000.
The Jackson Laboratory launched the Tallwood Canine Cancer Research Initiative, which will create a biobank of dog tumors that the nonprofit biomedical research institution plans to use and share with researchers around the world to provide new insights into cures for cancer in humans and dogs.
DONALD BROWN donated $30 million to Indiana University School of Medicine to establish the Brown Center for Immunotherapy. The Brown Center for Immunotherapy will initially focus on multiple myeloma and triple negative breast cancer, two diseases for which the School of Medicine and its clinical partner Indiana University Health have a strong foundation of talent,... […]
PROTON PARTNERS INTERNATIONAL LTD will invest £30 million in a new cancer center which will be located at the Thames Valley Science Park, UK, offering proton beam therapy among other conventional cancer therapies. Located in Reading, Berkshire, the center will be the third to be built in the UK by Proton Partners and will help... […]
ELLIS NEUFELD was appointed clinical director, physician-in-chief and executive vice president of St. Jude Children’s Research Hospital. Beginning in March 2017, Neufeld will oversee the organization’s academic clinical departments and all clinical operations. The appointment comes as St. Jude looks to increase the number of cancer patients treated at its campus and on protocols around... […]
BILL ANDERSON was named CEO of Genentech, which is a member of the Roche Group, effective Jan. 1, 2017. He takes over from Ian T. Clark who retires at the end of 2016 after 14 years of service. Anderson, who is also the head of North American commercial operations, has served in a number of... […]
FRANCIS COLLINS, the NIH director, received the 2017 Public Service Award from the Federation of American Societies for Experimental Biology “for his outstanding accomplishments in the communication of science.” “Francis Collins is a model of scientific citizenship. His passion for public education has been an inspiration, and his leadership has motivated thousands of scientists to... […]
